Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients

This study has been completed.
Information provided by (Responsible Party):
Sangart Identifier:
First received: December 15, 2010
Last updated: August 20, 2013
Last verified: August 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)